First Citizens Bank’s Silicon Valley Bank division, along with lending partner Trinity Capital, provided a $125 million warehouse facility to Parafin, a financial technology infrastructure startup.
Trinity Capital committed $25 million in growth capital to Moxe Health, a healthcare interoperability and clinical data exchange company. This growth capital will enable the team at Moxe Health to continue scaling operations.
Trinity Capital committed $20 million in equipment financing to Formlogic, a provider of autonomous precision manufacturing services intended for space companies.
Trinity Capital committed $15 million in growth capital to Kafene, a point-of-sale platform that helps retailers offer consumers more flexible purchase options through lease-to-own (LTO) agreements.
Trinity Capital originated $340.7 million of total new commitments in Q4/23, bringing the company’s total new commitments for 2023 to $830.7 million. Additionally, Trinity funded a company record $641.8 million of investments in 2023.
Trinity Capital’s board of directors named Michael Testa CFO, effective immediately. Testa succeeded David Lund, who will remain on the team as a consultant, focusing on strategic growth initiatives for the company.
Trinity Capital committed $30 million in growth capital to Cart.com, a provider of unified commerce and logistics solutions that enable merchants to sell and fulfill anywhere.
Trinity Capital expanded its Phoenix headquarters, doubling the total space leased at its corporate headquarters at 1 North 1st St. to 30,000 square feet by expanding to the fourth floor from its existing third floor offices.
Trinity Capital committed $40 million in term loans to Taysha Gene Therapies, a clinical-stage gene therapy company, pursuant to a loan and security agreement by and among Taysha, the lenders party thereto and Trinity as administrative agent and collateral agent for the lenders.
Trinity Capital appointed Ryan Kaeding managing director of life sciences in San Diego. Kaeding, a veteran in the venture ecosystem, has been supporting venture capital-backed growth-stage companies for more than 20 years.